Abstract
Objective
The aim of this study is to analyze the differences in independent prognostic factors of cancer-specific survival (CSS) and overall survival (OS) in patients with different grades of histologic differentiation of colorectal cancer (CRC) who received preoperative neoadjuvant chemotherapy (NAC) and to establish a nomogram for predicting postoperative survival based on moderately differentiated CRC.
Methods
We analyzed CRC patients from the SEER database who received NAC before operation between 2010 and 2015. The Kaplan-Meier curves were drawn to describe the differences in CSS and OS of CRC patients with different histologic grades of differentiation. Cox regression analysis was used to determine the independent prognostic factors. Nomograms were established to predict CSS and OS at 3 and 5 years by integrating independent prognostic factors. The calibration curve, receiver operating characteristic (ROC) curve, and C-index were used to verify nomograms.
Results
A total of 6481 patients with CRC who received preoperative NAC were included in this study. Patients with different grades of histologic differentiation had significant differences in CSS and OS (P < 0.001), and the independent prognostic factors of different grades of histologic differentiation showed heterogeneity. In patients with moderately differentiated grade CRC, the independent prognostic factors for CSS and OS were age, race, marital status, serum carcinoembryonic antigen (CEA) level before treatment, site of primary tumor, histologic type, pT stage, pN stage, liver metastasis, and lung metastasis. Nomograms were established based on the independent prognostic factors of moderately differentiated grade CRC, and its calibration curves, area under the curve (AUC), and C-index showed good prediction accuracy.
Conclusions
The independent prognostic factors of CSS and OS are different in patients with different grades of histologic differentiation of CRC who received NAC before the operation. Nomograms can be used to predict the survival of patients with moderately differentiated grade CRC who received preoperative NAC and to assist clinicians in making clinical decisions.
Similar content being viewed by others
Data availability
Publicly available datasets were analyzed in this study. This data can be found here: Surveillance, Epidemiology, and End Results (SEER) database (https://seer.cancer.gov/).
References
Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7–30
Siegel RL, Miller KD, Sauer AG et al (2020) Colorectal cancer statistics, 2020. CA Cancer J Clin 70:145–164
Deidda S, Elmore U, Rosati R et al (2021) Association of delayed surgery with oncologic long-term outcomes in patients with locally advanced rectal cancer not responding to preoperative chemoradiation. JAMA Surg 156:1141–1149
Benson AB, Venook AP, Cederquist L et al (2017) Colon cancer, version 1.2017 clinical practice guidelines in oncology. J Natl Compr Canc Netw 15:370–398
Benson A, Venook AP, Al-Hawary MM et al (2018) Rectal cancer, version 2.2018 clinical practice guidelines in oncology. J Natl Compr Canc Netw 16:874–901
Shivji S, Conner JR, Barresi V, Kirsch R (2020) Poorly differentiated clusters in colorectal cancer: a current review and implications for future practice. Histopathol 77:351–368
Yang J, Jin W, Lin Z, Li S (2023) New personal model for forecasting the outcome of patients with histological grade III-IV colorectal cancer based on regional lymph nodes. J Oncol 2023:6980548
Jurescu A, Dema A, Vaduva A et al (2022) Poorly differentiated clusters and tumor budding are important prognostic factors in colorectal carcinomas. Bosn J Basic Med Sci 22:164–177
Komori K, Kanemitsu Y, Ishiguro S et al (2011) Clinicopathological study of poorly differentiated colorectal adenocarcinomas: comparison between solid-type and non-solid-type adenocarcinomas. Anticancer Res 31:3463–3467
Li Q, Bao J, Zhang Y et al (2023) Predictive value of CT-based extracellular volume fraction in the preoperative pathologic grading of rectal adenocarcinoma: a preliminary study. Eur J Radiol 163
Liu XS, Sha L, Huang C et al (2023) A nomogram prediction model for lymph node metastasis risk after neoadjuvant chemoradiotherapy in rectal cancer patients based on SEER database. Front Oncol 13:9
Balachandran VP, Gonen M, Smith JJ, DeMatteo RP (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16:E173–E180
Saadoun JE, Meillat H, Zemmour C et al (2022) Nomogram to predict disease recurrence in patients with locally advanced rectal cancer undergoing rectal surgery after neoadjuvant therapy: retrospective cohort study. Bjs Open 6:9
Lin YF (2022) A prognostic nomogram for stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgical resection. Bmc Surg 22:11
Morton D, Seymour M, Magill L et al (2023) Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial. J Clin Oncol 41:1541–1552
Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th Edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474
Han LY, Mo SB, Xiang WQ et al (2020) Comparison of four lymph node staging systems for predicting prognosis for stage IV rectum cancer. Ann Transl Med 8:13
Bonetti LR, Barresi V, Bettelli S, Domati F, Palmiere C (2016) Poorly differentiated clusters (PDC) in colorectal cancer: what is and ought to be known. Diagn Pathol 11:4
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019) Colorectal cancer. Lancet 394:1467–1480
Luo YS, Liu LL, Liu DH et al (2023) Extracellular volume fraction determined by equilibrium contrast-enhanced CT for the prediction of the pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Eur Radiol 10
Yang CB, He TP, Duan HF et al (2017) Quantitative assessment of the degree of differentiation in colon cancer with dual-energy spectral CT. Abdom Radiol 42:2591–2596
Sharma BR, Kanneganti TD (2023) Inflammasome signaling in colorectal cancer. Transl Res 252:45–52
Anderson NM, Simon MC (2020) The tumor microenvironment. Curr Biol 30:R921–R925
Zhong PJ, Yang B, Pan F, Hu F (2023) Temporal trends in Black-White disparities in cancer surgery and cancer-specific survival in the United States between 2007 and 2015. Cancer Med 11
Brenne SS, Ness-Jensen E, Edna TH, Lydersen S, Laugsand EA (2023) Risk factors for right colon, left colon and rectal cancers differ between men and women: the population-based HUNT study in Norway. Colorectal Dis 12
Lee RM, Cardona K, Russell MC (2019) Historical perspective: Two decades of progress in treating metastatic colorectal cancer. Surg Oncol 119:549–563
Alhumaid A, AlYousef Z, Bakhsh HA, AlGhamdi S, Aziz MA (2018) Emerging paradigms in the treatment of liver metastases in colorectal cancer. Crit Rev Oncol Hematol 132:39–50
Japuntich SJ, Kumar P, Pendergast JF et al (2019) Smoking status and survival among a national cohort of lung and colorectal cancer patients. Nicotine Tob Res 21:497–504
Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. New England J Med 351:1731–1740
Sebag-Montefiore D, Stephens RJ, Steele R et al (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373:811–820
Author information
Authors and Affiliations
Contributions
(I) Conception and design: Jianping Zhang, Xiagang Luo, Yimin E; (II) Administrative support: Jianping Zhang; (III) Provision of study materials or patients: Xiagang Luo, Yimin E, Jie Wu; (IV) Collection and assembly of data: Xiagang Luo, Yimin E; (V) Data analysis and interpretation: Xiagang Luo, Yimin E, Chen Lu; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Xiagang Luo, Yimin E, Jie Wu contributed equally to this work.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Informed consent
The SEER database is an open public database, and the release of data from the SEER database does not require informed patient consent.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Luo, X., E, Y., Wu, J. et al. Analysis of prognostic factors in different grades of histologic differentiation in colorectal cancer patients receiving preoperative neoadjuvant chemotherapy and establishment of prognostic nomograms for moderately differentiated grade. Int J Colorectal Dis 38, 237 (2023). https://doi.org/10.1007/s00384-023-04539-x
Accepted:
Published:
DOI: https://doi.org/10.1007/s00384-023-04539-x